Immunex Corporation develops, manufactures, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders. It offers products, such as Enbrel that is used in the treatment of rheumatoid arthritis; Novantrone, which is used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine for use in bone marrow transplant patients. The company has franchise operations. It has a strategic alliance with American Home Products. The company was founded in 1981 and is based in Seattle, Washington. As of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc.

Canji, Inc., part of Merck & Co., Inc., is a company headquartered in San Diego, CA, specializing in medical laboratories. Schering-Plough Corp., now part of Merck & Co., Inc. acquired Canji, Inc. on February 02, 1996 for $54.50 million.

KUMHO HT, Inc. engages in the manufacture of lighting products for automotive industry. Its products include light emitting diodes (LED), LED modules, lamps for wedge, festoon, surface mount device, rear, and indicator lamps. The company was founded on July 15, 1988 and is headquartered in Gwangju, South Korea.

Korea Institute of Radiological & Medical Sciences specializes in radiation technology, research, development, genomics, and radiotherapy.

cureab is a swiss based biotech company that was founded in 2012. -cureab is focussed on research in inflammation and oncology. -cureab develops therapeutic antibodies from target identification to clinical testing. -two monoclonal antibodies are in late stage pre-clinical development. -cureab welcomes new partnerships with academia and industry.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

The Korea Atomic Energy Research Institute (KAERI) in Daejeon, South Korea was established in 1959 as the sole professional research-oriented institute for nuclear power in South Korea, and has rapidly built a reputation for research and development in various fields. In 1995 KAERI designed and constructed the nation's first multipurpose research reactor, HANARO based on the Canadian MAPLE design. KAERI is dedicated to finding a wide range of uses for atomic energy. As examples, KAERI developed the world's first radiopharmaceutical "Milican injection" for treating liver cancer.

Suzhou Xuguang Kexing Antibody Biotechnology Co., Ltd., established on 2019-09-27, Business scope includes research and development,Sales:biotechnology product;research and development,Production:one type,Class II,Three types of in vitro diagnostic reagents;Biotechnology R&D Services;technology development,technical consulting,Technical Services,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Northwest Biotherapeutics is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States and is incorporated in Delaware, USA. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company’s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. The Company’s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies.

DiNonA, Inc. engages in the development of bio-drugs and medical devices. It operates through the Bio Medical and Medical Equipment business divisions. It offers antibody treatments, laser medical devices, and diagnostic reagents. The company was founded on February 11, 1999 and is headquartered in Seoul, South Korea.

Lukas Biomedical, Inc. engages in the lease and sale of medical equipment. It operates through the Electronic Commerce and Medical Management segments. It also offers biotechnology beauty products and immune cell therapy. The company was founded on December 26, 2013 and is headquartered in Taipei, Taiwan.

Galpharma targets research and development of sugar chain-binding proteins focus on galectin 9. It provides information on functional analysis of the protein in each disease and substance that involves sugar chain-binding proteins to the pharmaceutical companies. It is founded in 2000 in Kagawa, Japan.

Miaoshun (Shanghai) Biotechnology Co., Ltd., established on 2014-07-01, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;sales agent;R&D and application of cell technology;Biochemical product technology research and development;Research and development of bio-based materials technology;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Natural science research and experimental development;Health Consulting Services(Does not include medical services);Information Consulting Service(Not including licensing information consulting services);data processing services;Business Management Consulting;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Tianjin Newsay Biotechnology Co., Ltd., established on 2014-04-23, Operating range includes cells,Nucleic acid and protein and other related biotechnology research,development and transfer;Biotechnology product development,technical consulting,Technical Services;Wholesale of Class I Medical Devices,retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Central Institute for Experimental Animals (CIEA) (実験動物中央研究所) is a research center for experimental animals in Japan. It was founded by Tatsuji Nomura in 1952 with the mission of improving the level of biomedical research.

Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. Incyte's product pipeline is currently focused on oncology and inflammation and includes compounds in various stages of development. Through partnerships with [Novartis](/organization/novartis), [Eli Lilly](/organization/eli-lilly), and [Pfizer](/organization/pfizer), Incyte intends to promote the clinical development and global commercialization of several of their compounds.